Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris

ClinicalTrials.gov ID: NCT01628549

Public ClinicalTrials.gov record NCT01628549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:50 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of 3 Different Doses of a Novel Tetracycline Compared to Placebo in the Treatment of Facial Acne Vulgaris, Study PR-10411

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and effectiveness of 3 strengths of P005672-HCl compared to placebo for the treatment of moderate to severe facial acne vulgaris.

Study identification

NCT ID
NCT01628549
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Almirall, S.A.
Industry
Enrollment
285 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2012 (Actual)
Primary completion
Nov 16, 2012 (Actual)
Completion
Jan 31, 2013 (Actual)
Last update posted
Feb 1, 2019

2012 – 2013

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Warner Chilcott Investigational Site Mobile Alabama 36608 —
Warner Chilcott Investigational Site Tucson Arizona 85710 —
Warner Chilcott Investigational Site Hot Springs Arkansas 71913 —
Warner Chilcott Investigational Site Los Angeles California 90045 —
Warner Chilcott Investigational Site San Diego California 92123 —
Warner Chilcott Investigational Site Santa Monica California 90404 —
Warner Chilcott Investigational Site Clearwater Florida 33761 —
Warner Chilcott Investigational Site Coral Gables Florida 33134 —
Warner Chilcott Investigational Site Gainesville Florida 32605 —
Warner Chilcott Investigational Site Miami Florida 33175 —
Warner Chilcott Investigational Site Miramar Florida 33027 —
Warner Chilcott Investigational Site Pinellas Park Florida 33781 —
Warner Chilcott Investigational Site Arlington Heights Illinois 60005 —
Warner Chilcott Investigational Site Chicago Illinois 60611 —
Warner Chilcott Investigational Site Granger Indiana 46530 —
Warner Chilcott Investigational Site Indianapolis Indiana 46256 —
Warner Chilcott Investigational Site Louisville Kentucky 40202 —
Warner Chilcott Investigational Site Boston Massachusetts 02135 —
Warner Chilcott Investigational Site Fridley Minnesota 44532 —
Warner Chilcott Investigational Site St Louis Missouri 63117 —
Warner Chilcott Investigational Site Berlin New Jersey 08009 —
Warner Chilcott Investigational Site Albuquerque New Mexico 87106 —
Warner Chilcott Investigational Site Rochester New York 14609 —
Warner Chilcott Investigational Site Rochester New York 14623 —
Warner Chilcott Investigational Site Charlotte North Carolina 28209 —
Warner Chilcott Investigational Site Salisbury North Carolina 28144 —
Warner Chilcott Investigational Site Wilmington North Carolina 28401 —
Warner Chilcott Investigational Site Cincinnati Ohio 45249 —
Warner Chilcott Investigational Site Portland Oregon 97210 —
Warner Chilcott Investigational Site Philadelphia Pennsylvania 19103 —
Warner Chilcott Investigational Site Greer South Carolina 29650 —
Warner Chilcott Investigational Site Arlington Texas 76011 —
Warner Chilcott Investigational Site Austin Texas 78759 —
Warner Chilcott Investigational Site Houston Texas 77065 —
Warner Chilcott Investigational Site Plano Texas 75093 —
Warner Chilcott Investigational Site San Antonio Texas 78229 —
Warner Chilcott Investigational Site Sandy City Utah 84070 —
Warner Chilcott Investigational Site Lynchburg Virginia 24501 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01628549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2019 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01628549 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →